Conference Coverage

Intranasal Drug Delivery Bypasses the Blood–Brain Barrier

Neurology Reviews. 2016 April;24(4):1, 40-41

References

Suggested Reading
Danielyan L, Schäfer R, von Ameln-Mayerhofer A, et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson’s disease. Rejuvenation Res. 2011;14(1):3-16.
Danielyan L, Beer-Hammer S, Stolzing A, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell Transplant. 2014;23(suppl 1):S123-S139.
Frey WH 2nd. Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson’s disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer’s and other CNS disorders. J Nat Sci. 2015;1(1):e23.
Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metab. 2015;35(3):371-381.

Intranasal Drug Delivery Bypasses the Blood–Brain Barrier

References

Pages

Recommended Reading